Centene initiated with an Overweight at MUFG. MUFG analyst Jason Twizell started Centene with an Overweight rating and $170 price target. The analyst sees an attractive risk/reward profile given the stock’s discount to peers. He believes Centene’s “significant” Medicaid and Medicare growth opportunities make the discount unwarranted.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.